Detailed answers about MANCHESTER RETINA AND UVEITIS CLINIC LIMITED, including incorporation, status, business activity, and accounts information.
When was MANCHESTER RETINA AND UVEITIS CLINIC LIMITED founded?
MANCHESTER RETINA AND UVEITIS CLINIC LIMITED was officially incorporated on 28 March 2017 and is registered under company number 10694062. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MANCHESTER RETINA AND UVEITIS CLINIC LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MANCHESTER RETINA AND UVEITIS CLINIC LIMITED?
MANCHESTER RETINA AND UVEITIS CLINIC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MANCHESTER RETINA AND UVEITIS CLINIC LIMITED do?
MANCHESTER RETINA AND UVEITIS CLINIC LIMITED operates in the following sector: 86210 - General medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is MANCHESTER RETINA AND UVEITIS CLINIC LIMITED's registered address?
The registered office address of MANCHESTER RETINA AND UVEITIS CLINIC LIMITED is 16 VALLEY ROAD, CHEADLE, CHESHIRE, UK, UNITED KINGDOM, SK8 1HY. This is the official address filed with Companies House for legal and statutory correspondence.
Is MANCHESTER RETINA AND UVEITIS CLINIC LIMITED financially stable?
The most recent accounts for MANCHESTER RETINA AND UVEITIS CLINIC LIMITED were made up to 31 March 2025, filed as UNAUDITED ABRIDGED. Next accounts are due by 31 December 2026.